Quality Systems & Policy

Every Quality Systems & Policy course in the Zentrum24 Academy library. Read the first two pages of any of them free.

• Adventitious Agent Control and Contamination ResponsePreventing adventitious agent ingress — raw material risk, segregation and containment, detection, and the response if a contamination is suspected.
• Analytical Method Validation, Qualification, and Transfer PolicySite policy on validating, qualifying and transferring analytical methods — what each term requires, protocol content, acceptance criteria and approvals.
• Aseptic Process Simulation and Media Fill PolicyThe policy behind media fills — frequency and matrix coverage, unit numbers, interventions to include, acceptance criteria, and what a failure obliges.
• Change Management Policy and Compliance FrameworkHow change is governed site-wide — categories and approval levels, risk assessment expectations, implementation control, and verifying that it worked.
• Combination Product Design and Component Quality Control PolicyDesign control for drug-device combination products — design inputs and outputs, component specifications, human factors, and device constituent control.
• Combination Product Manufacturing and CGMP ComplianceCombination products under both drug and device rules — the streamlined cGMP approach, design and device history files, and complaint handling obligations.
• Drug Product Campaigning PolicyCampaigned manufacture without cross-contamination — campaign length limits, changeover cleaning, monitoring, and the risk assessment behind the limits.
• Elemental Impurities Risk Management and Control PolicyICH Q3D in practice — identifying potential elemental impurities, risk assessment across materials and equipment, permitted daily exposure, and controls.
• Facility Bioburden Control and Safety OversightKeeping facility bioburden under control — cleaning and disinfection, personnel and material flow, monitoring, and oversight when limits start to move.
• Gap Analysis and Compliance Assessment PolicyGap analysis against a regulation or standard — building the requirement matrix, evidencing compliance, rating gaps, and turning them into a remediation plan.
• Integrated Site Commissioning and Qualification (C&Q) PolicyAn integrated, requirements-driven approach to C&Q — leveraging vendor documentation, subject matter expert approval, and what the qualification record holds.
• Measurement Systems Analysis (MSA) and Gauge R&R PolicyProving a measurement system is capable before trusting its data — repeatability and reproducibility, bias and linearity, acceptance thresholds, and repeats.
• Continued Process Verification (CPV) PolicyStage 3 of process validation — the CPV plan, parameters and attributes monitored, control charts and capability, and when a signal becomes an action.
• Statistical Practice in Sterile Manufacturing (Policy Guidance)Choosing and defending statistical methods — sample size and confidence, normality, tolerance intervals and capability indices, and not overstating a result.
• Multi-product Processing and Cross-Contamination PreventionSharing a facility between products safely — health-based exposure limits, dedicated versus shared equipment, changeover, and airflow segregation.
• Particulate Control Policy for Sterile Drug ManufacturingDesigning particulate out of the process — material and component controls, gowning and cleanroom practice, equipment design, inspection, and the limits.
• Particulate Identification and Assessment PolicyWhat happens when a particle is found — collection and preservation, identification techniques, source attribution, patient risk, and batch impact.
• Pharmaceutical Cold Chain Management PolicyHolding temperature from storage to delivery — qualified storage and shippers, lane qualification, monitoring devices, and assessing an excursion on arrival.
• Pharmaceutical Container Closure Integrity (CCI) Lifecycle StrategyContainer closure integrity across the lifecycle — maximum allowable leakage limit, method selection and validation, and integrity from development on.
• Pharmaceutical Manufacturing Maintenance Operations and Protocol PolicyMaintenance under GMP — planned and breakdown work, permits and area release, GMP-critical spares and lubricants, and post-maintenance verification.
• Phase-Appropriate Pharmaceutical Stability Testing PolicyMatching stability effort to development phase — clinical versus commercial protocols, storage conditions, test frequency, and a shelf life you can defend.
• Protocol for Particulate Identification in Product RetainsInvestigating particulate in a retained unit — extraction without introducing contamination, identification, comparison with the process, and conclusions.
• Quality Assurance Floor Support in Primary ManufacturingQA on the floor, not at a desk — in-process checks and line clearance, real-time batch record review, deviation triage, and calling a stop when needed.
• Quality Risk Management PolicyICH Q9 as a working method — when a risk assessment is required, choosing a tool, scoring and documenting risk, mitigation, and reviewing it later.
• Raw Material Risk and Quality PolicyRisk-rating raw materials by criticality and source — specification setting, supplier qualification, testing depth, and periodic reassessment.
• Residual Solvent Control PolicyICH Q3C class 1 to 3 solvents — setting limits by permitted daily exposure, the options for calculating them, testing strategy, and justifying a skip test.
• Satellite Sample Acceptance and Material Testing RequirementsAccepting samples taken away from the laboratory — sampler qualification, container and labelling, transport and hold time, and when to reject a sample.
• System Qualification and Validation Policy (DP-MFG-FACILITY)Site policy for qualifying systems — V-model deliverables at each stage, risk-based test depth, handling deviations in a protocol, and the summary report.
• Technical Transfer Policy for Sterile Drug ManufacturingMoving a product between sites or scales — transfer plan and gap assessment, process and analytical transfer, engineering and PPQ batches, and acceptance.
• The Fundamentals of Material Control and CGMP LogisticsMaterial control from receipt to point of use — quarantine and status labelling, segregation, FEFO issue, reconciliation, and traceability through the site.
• The New Product Assessment PolicyThe policy governing new product intake — who assesses what, the questions each function must answer, staged decision points, and the record of the decision.
• User Requirements Specification (URS) Governance and StandardsWriting requirements that can actually be tested — separating need from design, traceability into qualification, approval, and controlling changes to the URS.